Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TOFA (MDL14514) is an allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 32.00 | |
5 mg | In stock | $ 48.00 | |
10 mg | In stock | $ 63.00 | |
25 mg | In stock | $ 117.00 | |
50 mg | In stock | $ 197.00 | |
100 mg | In stock | $ 372.00 | |
200 mg | In stock | $ 549.00 | |
500 mg | In stock | $ 869.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | TOFA (MDL14514) is an allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA). |
In vitro | TOFA (5-tetradecyloxy-2-furoic acid) effectively inhibits the proliferation of examined cancer cells by inducing apoptosis, arresting them in the G0/G1 cell cycle phase, and exhibiting time and dose-dependent cytotoxic effects. It specifically targets Acetyl-CoA-carboxylase-α (ACCA), a crucial enzyme in fatty acid synthesis regulation, leading to decreased fatty acid synthesis, caspase activation, and cell death, particularly in prostate cancer (PCa) cell lines. Additionally, TOFA demonstrates significant cytotoxicity toward lung cancer cells NCI-H460 and colon carcinoma cells HCT-8 and HCT-15, showcasing IC50 values around 5.0, 5.0, and 4.5 μg/mL respectively. At concentrations ranging from 1.0 to 20.0 μg/mL, it blocks fatty acid synthesis and prompts cell death in a dose-dependent manner. Furthermore, TOFA has proven cytotoxic effects on COC1 and COC1/DDP cells, with IC50 values approximately at 26.1 and 11.6 μg/mL, respectively. |
In vivo | The tumor growth rate is signifi?cantly inhibited by TOFA compared with the DMSO treated control mice (1649±356.3 vs. 5128±390.4 mm3. No toxicity is observed in the heart, liver, spleen, lung, kidney and intestinal tissues. TOFA inhibits COC1/DDP cell growth in ovarian tumor mouse xenografts. By inhibiting ACC, TOFA may be a promising small molecule agent for ovarian cancer therapy. |
Cell Research | NCI-H460, human lung cancer cells, and HCT-8 and HCT-15 cells (5,000/well) are seeded in 96-well plates overnight and then exposed to TOFA at indicated concentrations (0, 1, 5, 10, 20, 50 μg/mL) for 72 hours. Viable cells are detected using MTT assay[1]. |
Synonyms | MDL14514, RMI14514 |
Molecular Weight | 324.45 |
Formula | C19H32O4 |
CAS No. | 54857-86-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6.88 mg/mL (21.19 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TOFA 54857-86-2 Metabolism Acetyl-CoA Carboxylase MDL14514 inhibit RMI-14514 ACC, Acetyl Coenzyme A Carboxylase RMI 14514 Inhibitor RMI14514 MDL-14514 MDL 14514 inhibitor